Comments on: Merck-Ridgeback’s oral drug lowers hospitalisation risk in Covid-19 trial /news/merck-ridgebacks-molnupiravir-covid-19/ The leading site for news and procurement in the pharmaceutical industry Thu, 28 Oct 2021 12:06:03 +0000 hourly 1 https://wordpress.org/?v=6.6.2